Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,929–1,936 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
GSK plc American Depositary Shares (Each representing two) Sotrovimab (VIR-7831 / GSK4182136) - (COMET-TAIL) COVID-19 BLA Filing Intramuscular COVID-19
Guardant Health Inc. Camizestrant - (SERENA-6) Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Metastatic Breast Cancer (mBC) PDUFA Data Released Oral Oncology
Guardant Health Inc. Camizestrant - (SERENA-6) Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Metastatic Breast Cancer (mBC) PDUFA Data Released Oral Oncology
Gyre Therapeutics Inc. Hydronidone (F351) MASH-associated liver fibrosis Phase 3 Ongoing Oral Gastroenterology
Gyre Therapeutics Inc. Dalcinonacog alfa – DalcA Hemophilia B Phase 2b Ongoing Intravenous Hematology
Gyre Therapeutics Inc. Marzeptacog alfa (MAA-304) - (Crimson 1) Hemophilia Phase 3 Trial Discontinued Intravenous Hematology
Halozyme Therapeutics Inc. VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) with ENHANZE - (ADHERE) Chronic inflammatory demyelinating polyneuropathy (CIDP) Phase 2 Data Released Subcutaneous injection Neurology
Halozyme Therapeutics Inc. Efgartigimod - (ADHERE) Chronic inflammatory demyelinating polyneuropathy (CIDP) BLA Filing Data Released Intravenous Neurology
1…240241242243244…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.